Singapore: US FDA has accepted Actavis' New Drug Application (NDA) for a progestin-only transdermal contraceptive patch (Norethindrone Transdermal Delivery System) for use by women to prevent pregnancy. The acceptance of the NDA for... Read more
Singapore: Gilead Sciences' phase II study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational, targeted,... Read more
Singapore: BioDuro, a PPD Company, has opened a new state-of-the-art laboratory in Shanghai, China, strengthening its ability... Read more
Singapore: Boehringer Ingelheim has initiated phase III study (POLO-AML-2) investigating volasertib, a selective and potent polo-like kinase... Read more
Singapore: Asian Myeloma Network is developing a regional collaboration of medical specialists across Asia to study the rising burden of... Read more
Singapore: Alchemia has completed enrollment of patients in a pivotal phase III clinical trial evaluating its lead product, HA-Irinotecan,... Read more
Singapore: Prima BioMed has commenced recruitment of patients into the Canvas (Cancer Vaccine Study) trial in Europe. Prima has authorized... Read more
Singapore: Japan-based Otsuka Pharmaceutical and H Lundbeck have received US FDA approval for Abilify Maintena (aripiprazole) extended-release... Read more
Singapore: A new study by GlobalData has revealed that New Zealand's Pharmaceutical Management Agency's (PHARMAC) is emphasising on generics,... Read more
Singapore: Crystal Pharmatech, a technology-driven solid-state research contract research organization (CRO) based China, has partnered... Read more
Singapore: Genentech's omalizumab has shown success in reducing disease severity in patients with moderate to severe chronic idiopathic... Read more
Singapore: A new study by researchers at Columbia University Medical Center, US, revealed that injection of triglyceride lipid emulsions... Read more
Survey Box
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
